IgD multiple myeloma - A clinical profile and outcome with chemotherapy and autologous stem cell transplantation

Annals of Hematology

Volumn 84, Issue 2, 2005, Pages 115-117

  Wechalekar, Ashutosh ^a,b   Amato, Dominic ^c   Chen, Chris ^a   Stewart, A Keith ^a   Reece, Donna ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN D; MELPHALAN; PREDNISONE; RETICULIN; THALIDOMIDE; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE PAIN; CANCER MORTALITY; CANCER SURVIVAL; CHROMOSOME 13Q; CHROMOSOME DELETION 13; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HAIRY CELL LEUKEMIA; HUMAN; HYPERCALCEMIA; INTERPHASE; KARYOTYPE; KIDNEY FAILURE; LYMPHADENOPATHY; MALE; MULTIPLE MYELOMA; PANCYTOPENIA; PLASMACYTOMA; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DATA COLLECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN D; MALE; MIDDLE AGED; MULTIPLE MYELOMA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 11844284832     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0944-x     Document Type: Article

References (13)

1. Blade J, Kyle RA (1999) Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am 13(6):1259-1272 10626149
2. Jancelewicz Z, Takatsuki K, Sugai S, Pruzanski W (1975) IgD multiple myeloma. Review of 133 cases. Arch Intern Med 135(1):87-93 10.1001/archinte.135.1.87
3. Blade J, Lust JA, Kyle RA (1994) Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 12(11):2398-2404 1:STN:280:ByqD2Mvis1E%3D
4. Blade J, Vesole DH, Gertz M (2003) Transplantation for multiple myeloma: who, when, how often? Blood 102(10):3469-3477 10.1182/blood-2003-01-0073
5. Blade J, Samson D, Reece D et al (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102(5):1115-1123 10.1046/j.1365-2141.1998.00930.x
6. Chang H, Wechalekar A, Li L, Reece D (2004) Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: Evidence of distinct clonal origin. Cancer Genet Cytogenet 148(1):44-48 10.1016/S0165-4608(03)00217-6
7. Brouet JC, Fermand JP, Laurent G et al (1985) The association of chronic lymphocytic leukaemia and multiple myeloma: A study of eleven patients. Br J Haematol 59(1):55-66 1:STN:280:BiqC383lt1Y%3D
8. Kaufmann H, Ackermann J, Nosslinger T et al (2001) Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma - a report on two cases. Ann Hematol 80(8):474-478 10.1007/s002770100328
9. Aronowitz J, Baral E, Dalal BI (1993) Late transition of hairy cell leukemia to multiple myeloma. Am J Hematol 44(3):216-217 1:STN:280:ByuD38jgtFA%3D
10. Saif MW, Greenberg BR, Aronowitz J, Baral E, Dalal BI (2001) Multiple myeloma and hairy cell leukemia: A rare association or coincidence? Leuk Lymphoma 42(5):1043-1048 1:STN:280:DC%2BD3MnksVKgsQ%3D%3D
11. Meerkin D, Ashkenazi Y, Gottschalk-Sabag S, Hershko C (1994) Plasma cell dyscrasia with marrow fibrosis. A reversible syndrome mimicking agnogenic myeloid metaplasia. Cancer 73(3):625-628 1:STN:280:ByuC3s%2FitlE%3D
12. Krzyzaniak RL, Buss DH, Cooper MR, Wells HB (1988) Marrow fibrosis and multiple myeloma. Am J Clin Pathol 89(1):63-68 1:STN:280:BieC3czktlA%3D
13. Hartman HA Jr, Skoog D, Foley JF, Stone DB (1979) Response to adriamycin and CCNU in a patient with IgD multiple myeloma and myelofibrosis. Nebr Med J 64(7):201-205 112484